Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Cardiovascular risk perception and evidence--practice gaps in Australian general practice (the AusHEART study).

Heeley EL, Peiris DP, Patel AA, Cass A, Weekes A, Morgan C, Anderson CS, Chalmers JP.

Med J Aust. 2010 Mar 1;192(5):254-9.

PMID:
20201758
2.

Gaps in cardiovascular disease risk management in Australian general practice.

Webster RJ, Heeley EL, Peiris DP, Bayram C, Cass A, Patel AA.

Med J Aust. 2009 Sep 21;191(6):324-9.

PMID:
19769555
3.

Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study.

Turnbull F, Arima H, Heeley E, Cass A, Chalmers J, Morgan C, Patel A, Peiris D, Weekes A, Anderson C.

Eur J Cardiovasc Prev Rehabil. 2011 Jun;18(3):498-503. doi: 10.1177/1741826710389369. Epub 2011 Feb 11.

PMID:
21450654
4.

Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study).

Razavian M, Heeley EL, Perkovic V, Zoungas S, Weekes A, Patel AA, Anderson CS, Chalmers JP, Cass A.

Nephrol Dial Transplant. 2012 Apr;27(4):1396-402. doi: 10.1093/ndt/gfr599. Epub 2011 Nov 2.

5.

Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?

Monesi L, Avanzini F, Barlera S, Caimi V, Lauri D, Longoni P, Roccatagliata D, Tombesi M, Tognoni G, Roncaglioni MC.

Eur J Clin Pharmacol. 2005 Sep;61(8):595-601. Epub 2005 Jul 15.

PMID:
16021439
6.

How do the Australian guidelines for lipid-lowering drugs perform in practice? Cardiovascular disease risk in the AusDiab Study, 1999-2000.

Chen L, Rogers SL, Colagiuri S, Cadilhac DA, Mathew TH, Boyden AN, Peeters A, Magliano DJ, Shaw JE, Zimmet PZ, Tonkin AM; National Vascular Disease Prevention Alliance.

Med J Aust. 2008 Sep 15;189(6):319-22.

PMID:
18803535
7.

An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation.

Peiris DP, Joshi R, Webster RJ, Groenestein P, Usherwood TP, Heeley E, Turnbull FM, Lipman A, Patel AA.

J Med Internet Res. 2009 Dec 17;11(4):e51. doi: 10.2196/jmir.1258.

8.

Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit.

Peiris DP, Patel AA, Cass A, Howard MP, Tchan ML, Brady JP, De Vries J, Rickards BA, Yarnold DJ, Hayman NE, Brown AD.

Med J Aust. 2009 Sep 21;191(6):304-9.

PMID:
19769551
9.

Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention.

Carrington MJ, Retegan C, Johnston CI, Jennings GL, Stewart S.

J Clin Nurs. 2009 Mar;18(5):678-86. doi: 10.1111/j.1365-2702.2008.02507.x. Epub 2008 Nov 25.

PMID:
19077020
10.

National study of physician awareness and adherence to cardiovascular disease prevention guidelines.

Mosca L, Linfante AH, Benjamin EJ, Berra K, Hayes SN, Walsh BW, Fabunmi RP, Kwan J, Mills T, Simpson SL.

Circulation. 2005 Feb 1;111(4):499-510.

12.

Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk.

Rafter N, Connor J, Hall J, Jackson R, Martin I, Parag V, Vander Hoorn S, Rodgers A.

N Z Med J. 2005 Oct 7;118(1223):U1676.

PMID:
16224500
13.

National trends in the management of cardiovascular disease risk factors in children: second NHLBI survey of primary care physicians.

Kimm SY, Payne GH, Stylianou MP, Waclawiw MA, Lichtenstein C.

Pediatrics. 1998 Nov;102(5):E50.

PMID:
9794980
14.

Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.

Mohammed MA, El Sayed C, Marshall T.

Med Decis Making. 2012 May-Jun;32(3):498-506. doi: 10.1177/0272989X12437246. Epub 2012 Feb 22.

PMID:
22357626
15.
16.

Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.

Al-Omran M, Lindsay TF, Major J, Jawas A, Leiter LA, Verma S; Systematic Assessment of Vascular Risk Investigators.

Ann Vasc Surg. 2006 Sep;20(5):555-63.

PMID:
16871436
17.

Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study.

Gumbs PD, Verschuren WM, Mantel-Teeuwisse AK, de Wit AG, Hofman A, Trienekens PH, Stricker BH, de Boer A, Klungel OH.

Drugs Aging. 2006;23(9):733-41.

PMID:
17020397
18.

The impact of reimbursement criteria on the appropriateness of 'statin' prescribing.

Autier P, Creplet J, Vansant G, Brohet C, Paquot N, Muls E, Mullie P, Grivegnée AR.

Eur J Cardiovasc Prev Rehabil. 2003 Dec;10(6):456-62.

PMID:
14671469
19.

Dyslipidaemia in rural Australia: prevalence, awareness, and adherence to treatment guidelines in the Greater Green Triangle Risk Factor Study.

Janus ED, Tideman PA, Dunbar JA, Kilkkinen A, Bunker SJ, Philpot B, Tirimacco R, Mc Namara K, Heistaro S, Laatikainen T.

Med J Aust. 2010 Feb 1;192(3):127-32.

PMID:
20121678
20.

Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: lessons learned from a health care services study.

Zachariadou T, Stoffers HE, Christophi CA, Philalithis A, Lionis C.

BMC Health Serv Res. 2008 Jul 16;8:148. doi: 10.1186/1472-6963-8-148.

Items per page

Supplemental Content

Write to the Help Desk